These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9397222)

  • 1. References for health-related quality-of-life claims in prescription drug advertisements.
    Rothermich EA; Pathak DS
    Am J Health Syst Pharm; 1997 Nov; 54(22):2596-9. PubMed ID: 9397222
    [No Abstract]   [Full Text] [Related]  

  • 2. Health-related quality-of-life claims in prescription drug advertisements.
    Rothermich EA; Pathak DS; Smeenk DA
    Am J Health Syst Pharm; 1996 Jul; 53(13):1565-9. PubMed ID: 8809277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals.
    Lankinen KS; Levola T; Marttinen K; Puumalainen I; Helin-Salmivaara A
    Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):789-95. PubMed ID: 15486957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription medicines Code of Practice Authority investigates criticisms of advertisements.
    Simmonds H
    BMJ; 1998 Feb; 316(7129):476. PubMed ID: 9492704
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical evaluation of references in drug advertisements: an Indian experience.
    Lal A; Moharana AK; Chandra P; Ray A
    J Assoc Physicians India; 1996 Nov; 44(11):778-9. PubMed ID: 9251451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug advertisements in two dermatology journals: a critical comparison of IJDVL and JAAD.
    Gahalaut P; Chauhan S; Mishra N; Rastogi M; Thakur R
    Indian J Dermatol Venereol Leprol; 2014; 80(2):115-21. PubMed ID: 24685846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A content analysis of direct-to-consumer television prescription drug advertisements.
    Kaphingst KA; DeJong W; Rudd RE; Daltroy LH
    J Health Commun; 2004; 9(6):515-28. PubMed ID: 15764450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of claims and references found in Australian pharmacy journal advertisements.
    Mandoh M; Curtain CM
    Int J Pharm Pract; 2017 Oct; 25(5):365-370. PubMed ID: 27896882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of pharmaceutical advertisements in medical journals.
    Villanueva P; Peiró S; Librero J; Pereiró I
    Lancet; 2003 Jan; 361(9351):27-32. PubMed ID: 12517463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supported and unsupported claims in medicinal drug advertisements in Indian medical journals.
    Dhanaraj E; Nigam A; Bagani S; Singh H; Tiwari P
    Indian J Med Ethics; 2011; 8(3):170-4. PubMed ID: 22106646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advertising prescription-only drugs.
    Medawar C
    Lancet; 1998 May; 351(9115):1584. PubMed ID: 10326564
    [No Abstract]   [Full Text] [Related]  

  • 13. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
    Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
    CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-consumer advertising of prescription pharmaceuticals: strategic issues for the pharmaceutical industry.
    Smeeding JE
    Top Hosp Pharm Manage; 1990 May; 10(1):40-64. PubMed ID: 10128543
    [No Abstract]   [Full Text] [Related]  

  • 15. Heal the damage: prescription drug consumer advertisements and relative choices.
    Gilhooley M
    J Health Law; 2005; 38(1):1-44. PubMed ID: 15968938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Dispense as written" advertisements are demeaning to pharmacists.
    Mitchell JF; Pawlicki KS
    Am J Hosp Pharm; 1988 Oct; 45(10):2073. PubMed ID: 3228074
    [No Abstract]   [Full Text] [Related]  

  • 17. Advertising prescription-only drugs.
    Levin AA
    Lancet; 1998 May; 351(9115):1583. PubMed ID: 10326561
    [No Abstract]   [Full Text] [Related]  

  • 18. How evidence-based are advertisements in journals regarding the subspecialty of rheumatology?
    van Winkelen P; van Denderen JS; Vossen CY; Huizinga TW; Dekker FW
    Rheumatology (Oxford); 2006 Sep; 45(9):1154-7. PubMed ID: 16531437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advertising prescription-only drugs.
    Inlander CB
    Lancet; 1998 May; 351(9115):1583. PubMed ID: 10326562
    [No Abstract]   [Full Text] [Related]  

  • 20. Advertising prescription-only drugs.
    Goldstein MR
    Lancet; 1998 May; 351(9115):1583-4. PubMed ID: 10326563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.